The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Epidemiology of Melanoma
Open accessAbstract
Melanoma accounts for 1.7% of global cancer diagnoses and is the fifth most common cancer in the US. Melanoma incidence is rising in developed, predominantly fair-skinned countries, growing over 320% in the US since 1975. However, US mortality has fallen almost 30% over the past decade with the approval of 10 new targeted or immunotherapy agents since 2011. Mutations in the signaling-protein BRAF, present in half of cases, are targeted with oral BRAF/MEK inhibitor combinations, while checkpoint inhibitors are used to restore immunosurveillance likely inactivated by UV radiation. Although the overall 5-year survival has risen to 93.3% in the US, survival for stage IV disease remains only 29.8%. Melanoma is most common in white, older men, with an average age of diagnosis of 65. Outdoor UV exposure without protection is the main risk factor, although indoor tanning beds, immunosuppression, family history and rare congenital diseases, moles, and obesity contribute to the disease. Primary prevention initiatives in Australia implemented since 1988, such as education on sun-protection, have increased sun-screen usage and curbed melanoma incidence, which peaked in Australia in 2005. In the US, melanoma incidence is not projected to peak until 2022–2026. Fewer than 40% of Americans report practicing adequate protection (sun avoidance from 10 a.m.–4 p.m. and regular application of broad-spectrum sunscreen with an SPF > 30). A 2-4-fold return on investment is predicted for a US sun-protection education initiative. Lesion-directed skin screening programs, especially for those at risk, have also cost-efficiently reduced melanoma mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Reduced melanoma after regular sunscreen use: randomized trial follow-up
Green, A. C., Williams, G. M., Logan, V., & Strutton, G. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7078 · Cited by 799
Mitra, D., Luo, X., Morgan, A., Wang, J., Hoang, M. P., Lo, J., Guerrero, C. R., Lennerz, J. K., Mihm, M. C., Wargo, J. A., et al. (2012) · Nature · doi:10.1038/nature11624 · Cited by 497
Indoor Tanning and Risk of Melanoma: A Case-Control Study in a Highly Exposed Population
Lazovich, D., Vogel, R. I., Berwick, M., Weinstock, M. A., Anderson, K. E., & Warshaw, E. M. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1249 · Cited by 353 · cited 1×
“A dose–response relationship has been noted between total hours spent in a tanning bed, the number of sessions, or years of tanning bed usage, and melanoma risk [24].”
BackgroundShort- and Long-Wave UV Light (UVB and UVA) Induce Similar Mutations in Human Skin Cells
Kappes, U. P., Luo, D., Potter, M., Schulmeister, K., & Rünger, T. M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700093 · Cited by 200
Cited by
Deniz-Garcia, A., Fabelo, H., Rodriguez-Almeida, A. J., Zamora-Zamorano, G., Castro-Fernandez, M., Alberiche Ruano, M. D. P., Solvoll, T., Granja, C., Schopf, T. R., Callico, G. M., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/44030 · Cited by 268
Overview of skin cancer types and prevalence rates across continents
Roky, A. H., Islam, M. M., Ahasan, A. M. F., Mostaq, M. S., Mahmud, M. Z., Amin, M. N., & Mahmud, M. A. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.08.002 · Cited by 239
Wies, C., Schneider, L., Haggenmüller, S., Bucher, T.-C., Hobelsberger, S., Heppt, M. V., Ferrara, G., Krieghoff-Henning, E. I., & Brinker, T. J. (2024) · PLOS ONE · doi:10.1371/journal.pone.0297146 · Cited by 16
Metadata
- Authors
- Saginala, K., Barsouk, A., Aluru, J. S., Rawla, P., & Barsouk, A.
- Venue
- Medical Sciences
- Publisher
- MDPI AG
- Published
- 2021-10-20
- Volume
- 9
- Issue
- 4
- Pages
- 63
- ISSN
- 2076-3271 (ISSN-L)
- OpenAlex
- W3209099848
- Cited by
- 514
- References
- 5
- FWCI
- 26.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemiology of Melanoma. https://app.cochat.ai/papers/10.3390/medsci9040063
- The paper
- Saginala, K., Barsouk, A., Aluru, J. S., Rawla, P., & Barsouk, A. (2021). Epidemiology of Melanoma. Medical Sciences. https://doi.org/10.3390/medsci9040063
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.